What makes an exceptional psychedelic guide? Should access to psychedelics be as straightforward as obtaining a driver’s license? And what do over 100 studies reveal about psychedelic use outside clinical settings? In this episode of The Integration Session, we are joined by Dr. Mark Haden, a pioneer in psychedelic research, therapy, and drug policy reform. We discuss his recent study on naturalistic psychedelic use, his influential work in shaping psychedelic therapy training, and his vision for a public health approach to psychedelics. 

Mark Haden is a major figure in the field of psychedelic medicines, with a long list of past and present activities and responsibilities. Among—and beyond—these, he is the Clinical Supervisor for the Psychedelic Treatment Program at Qi Integrated Health and the Vice President of Business Development at Clearmind Medicine.  He is an instructor, teaching psychedelic therapy with the ATMA program and has written a book, the Manual for Psychedelic Guides (now in its third edition) which makes this information widely available. 

Mark served as the Executive Director for MAPS Canada for 10 years and is an Adjunct Professor at the University of British Columbia School of Population and Public Health. Mark has published numerous articles in respected journals, has presented at conferences and training events in many countries, and was awarded the Queen’s Diamond Jubilee Medal in 2013 for drug policy reform work. Mark also has a well-deserved reputation as an exciting speaker who never fails to engage and surprise audiences. You can read his latest publications and listen to his presentations here: www.markhaden.com